By Mariam Sunny and Kunal Das March 30 (Reuters) - The U.S. Food and Drug Administration has approved a higher dose of Biogen ...

European drug regulators approved the higher-dose version of Wegovy in February. Called Wegovy HD, the higher-dose drug ...

March 30 (Reuters) - The U.S. Food and Drug Administration has approved a higher-dose version of Biogen's drug for a rare ...

The FDA has approved a higher dose version of the GLP-1 drug Wegovy, which could lead to greater weight loss. The new dose is ...

The FDA has approved a higher 7.2 mg dose of Novo Nordisk’s Wegovy (Wegovy HD) for chronic weight management in adults with ...

In addition to the US, high-dose nusinersen (Spinraza; Biogen) is also approved in the European Union, Japan, and Switzerland. The patients who received nusinersen exhibited a 15.1-point improvement ...

Accelerated approval of semaglutide 7.2 mg establishes a higher-dose, once-weekly GLP-1 RA option for long-term weight ...

A stronger version of the popular weight loss drug Wegovy is on the way after federal regulators signed off on a higher dose.

• Skipping antibiotic doses can lower drug levels and reduce effectiveness. • Missing doses—especially multiple—can slow recovery and raise antibiotic resistance risk. • Don’t double doses; take a ...

If you miss a dose of GLP-1, you may be able to take it right away or wait until your next scheduled dose. It depends on the medication you take and how many doses you’ve missed. Glucagon-like peptide ...